Показано 0 из 0
Дата |
---|
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.199
|
0.202
|
0.208
|
0.198
|
0.208
|
0.202
|
|
0.2020
|
2 082 979.89
|
648.00
|
0.204
|
0.206
|
0.196
|
0.182
|
0.212
|
0.208
|
|
0.2020
|
6 841 843.79
|
1 211.00
|
0.221
|
0.223
|
0.219
|
0.208
|
0.226
|
0.222
|
|
0.2180
|
2 846 179.00
|
643.00
|
0.214
|
0.215
|
0.213
|
0.202
|
0.226
|
0.215
|
|
0.2130
|
3 970 439.93
|
723.00
|
0.21
|
0.212
|
0.234
|
0.209
|
0.235
|
0.213
|
|
0.2230
|
5 270 288.27
|
1 111.00
|
0.231
|
0.233
|
0.245
|
0.22
|
0.259
|
0.23
|
|
0.2340
|
25 484 077.89
|
3 947.00
|
0.19
|
0.191
|
0.198
|
0.189
|
0.198
|
0.19
|
|
0.1920
|
2 082 682.32
|
595.00
|
0.198
|
0.20
|
0.204
|
0.195
|
0.204
|
0.20
|
|
0.1990
|
1 554 269.93
|
558.00
|
0.20
|
0.201
|
0.207
|
0.198
|
0.208
|
0.204
|
|
0.2010
|
1 669 878.94
|
563.00
|
0.20
|
0.202
|
0.205
|
0.199
|
0.21
|
0.202
|
|
0.2040
|
2 476 741.58
|
610.00
|
Xbrane Biopharma AB is a biopharmaceutical company, develops and manufactures biosimilars and generic long-acting injectables. It offers products including Spherotide, a long-acting injectable with the active substance triptorelin for the treatment of prostate cancer, breast cancer, endometriosis, and myoma and Xlucane, a ranibizumab biosimilar for the treatment of age-related macular degeneration, diabetes-related macular edema, diabetic retinopathy, and retinal vein occlusion. The company has two segments that are Biosimilars and Long-acting Injectables.